ALESSANDRA FERRAJOLI to Immunocompromised Host
This is a "connection" page, showing publications ALESSANDRA FERRAJOLI has written about Immunocompromised Host.
Connection Strength
0.068
-
Phase II study of alemtuzumab in chronic lymphoproliferative disorders. Cancer. 2003 Aug 15; 98(4):773-8.
Score: 0.040
-
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy. N Engl J Med. 2018 10 11; 379(15):1443-1451.
Score: 0.028